CONTROVERSIAL MEASURE

Before leaving office, California Governor Gray Davis signed new laws to boost controversial stem cell research seen as key to new medical advances.

Related Videos
Related Content

Thinking Outside of the Box for Pediatric Acne With Latanya Benjamin, MD

May 20th 2023

The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma

August 5th 2021

FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum

March 7th 2023

The Cutaneous Connection: Episode 7- Tips and Tricks for Treating Young Skin of Color Patients

September 17th 2020

What’s New in Pediatric Dermatology With Elizabeth (Lisa) Swanson, MD

February 18th 2023

Novan Submits NDA for Berdazimer Gel for the Treatment of Molluscum Contagiosum

January 6th 2023

Thinking Outside of the Box for Pediatric Acne With Latanya Benjamin, MD

May 20th 2023

The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma

August 5th 2021

FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum

March 7th 2023

The Cutaneous Connection: Episode 7- Tips and Tricks for Treating Young Skin of Color Patients

September 17th 2020

What’s New in Pediatric Dermatology With Elizabeth (Lisa) Swanson, MD

February 18th 2023

Novan Submits NDA for Berdazimer Gel for the Treatment of Molluscum Contagiosum

January 6th 2023

Thinking Outside of the Box for Pediatric Acne With Latanya Benjamin, MD

May 20th 2023

The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma

August 5th 2021

FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum

March 7th 2023

The Cutaneous Connection: Episode 7- Tips and Tricks for Treating Young Skin of Color Patients

September 17th 2020

What’s New in Pediatric Dermatology With Elizabeth (Lisa) Swanson, MD

February 18th 2023

Novan Submits NDA for Berdazimer Gel for the Treatment of Molluscum Contagiosum

January 6th 2023
© 2023 MJH Life Sciences

All rights reserved.